MannKind Corp. (MNKD)
4.00
+0.05
(+1.27%)
USD |
NASDAQ |
Aug 31, 16:00
4.00
0.00 (0.00%)
After-Hours: 19:43
MannKind Cash from Operations (Annual) : 18.26M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 18.26M |
| December 31, 2024 | 42.11M |
| December 31, 2023 | 33.90M |
| December 31, 2022 | -80.70M |
| December 31, 2021 | -61.71M |
| December 31, 2020 | -28.13M |
| December 31, 2019 | -88.48M |
| December 31, 2018 | -37.73M |
| December 31, 2017 | -64.78M |
| December 31, 2016 | -78.09M |
| December 31, 2015 | -58.06M |
| December 31, 2014 | 4.086M |
| December 31, 2013 | -128.73M |
| Date | Value |
|---|---|
| December 31, 2012 | -119.86M |
| December 31, 2011 | -123.84M |
| December 31, 2010 | -148.65M |
| December 31, 2009 | -184.08M |
| December 31, 2008 | -271.29M |
| December 31, 2007 | -245.15M |
| December 31, 2006 | -189.79M |
| December 31, 2005 | -101.23M |
| December 31, 2004 | -59.91M |
| December 31, 2003 | -52.77M |
| December 31, 2002 | -48.67M |
| December 31, 2001 | -21.16M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| United Therapeutics Corp. | 1.561B |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Gilead Sciences, Inc. | 10.02B |
| Vertex Pharmaceuticals, Inc. | 3.631B |
| Ocugen, Inc. | -56.96M |